Court denies request to retract gov’t press release about convicted biotech CEO

court caseA doctor and former biotech CEO lost his appeal yesterday to force the federal government to retract a press release that he claims contained errors that damaged his reputation.

But this case isn’t so straightforward — the press release in question described the verdict in a case against former InterMune CEO W. Scott Harkonen, who was convicted in 2009 of hyping the results from the company’s lung disease drug in….you guessed it, a press release.

Here’s more from the U.S. government’s description of the 2009 case:

Continue reading Court denies request to retract gov’t press release about convicted biotech CEO

Former accounting prof adds his 32nd retraction

james-hunton
James Hunton

Another retraction makes 32.5 for former accounting professor James E. Hunton, and earns him the #10 slot on our leaderboard.

Though he resigned from his position at Bentley University in 2012, the story didn’t end there: In 2014, a university investigation found he’d committed misconduct in two papers. The, in June 2015, he notched 25 retractions all at once.

The newly retracted paper, “Effects of Anonymous Whistle- Blowing and Perceived Reputation Threats on Investigations of Whistle-Blowing Allegations by Audit Committee Members,” published in the Journal of Management Studies, suggests that, for public corporations, an anonymous whistleblower might not be as effective as an alert from a known source. The publisher Wiley put out a press release for the paper in 2010, and it succeeded in garnering some coverage.

Whether its conclusion remains valid is unclear, as Hunton didn’t provide evidence to support the validity of the data. The note explains:

Continue reading Former accounting prof adds his 32nd retraction

Plant paper pulled when authors can’t pay fees

KPSB_10_08_COVER.inddA paper on chicory plants — also known as “blue daisies” — won’t get its moment in the sun.

The “accepted author version” was published online in June, in Plant Signaling & Behavior. But before the so-called “version of record” could make it into an official issue of the journal — which is online-only — it was retracted.

Why? The authors apparently couldn’t pay the fees required to publish the paper. Here’s the short note, which is titled “Editorial Retraction:” Continue reading Plant paper pulled when authors can’t pay fees

Whistleblower released after being held for 4 days in Bangkok airport

Wyn Ellis
Wyn Ellis

A UK academic who’s lived in Thailand for decades has just been released from the Bangkok airport where he had been held for four days, the apparent result of his years-ago decision to expose a Thai official who had plagiarized his PhD thesis.

A university investigation several years ago eventually found that Wyn Ellis was, indeed, correct: Supachai Lorlowhakarn, a director of a Thai agency involved in intellectual property rights, had plagiarized 80% of his thesis about asparagus cultivation from other sources. In 2012, Times Higher Education reported that Supachai Lorlowhakarn lost his doctorate degree.

But when Ellis — a consultant and coordinator for the UN’s Sustainable Rice Platform based in Thailand — arrived at the Bangkok airport on Thursday, says The Guardian:

immigration officials showed him a 2009 letter in which Supachai describes him as a “danger to Thai society”.

Yesterday, he was freed: Continue reading Whistleblower released after being held for 4 days in Bangkok airport

5th retraction for Voinnet follows correction, EoC to PLOS Genetics paper

PLOS GeneticsAfter correcting a paper due to problematic figure panels, researchers led by high-profile biologist Olivier Voinnet have now retracted it, after “further analysis of the paper revealed flaws in the interpretation of” another figure.

PLOS Genetics published the retraction notice September 3 for the 2013 paper on the molecular details of embryonic stem cells in mice. First author Constance Ciaudo and Voinnet assume “full responsibility for the mistakes on this paper,” according to the note.

Continue reading 5th retraction for Voinnet follows correction, EoC to PLOS Genetics paper

Cancer drug paper nulled by “statistical errors”

12032Researchers have pulled a paper about a drug used to treat pancreatic tumors due to “statistical errors.”

The 2014 paper suggested a drug that appears to treat pancreatic tumors also works in Chinese patients. We’re not exactly sure what went wrong with “A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients,” however, because the retraction note is not particularly helpful. Here’s the whole thing, published in Medical Oncology: Continue reading Cancer drug paper nulled by “statistical errors”

Skin study retracted twice in triple publication rub

Indian Journal of DermatologyThe Indian Journal of Dermatology has retracted a paper on the potential genetic markers of psoriasis that had already been retracted once for redundant publication.

The journal is chalking it up to an “administrative error” that caused it to publish a paper that had already appeared in two other outlets.

According to one of the authors, the “most junior” author published the paper in 2008 in the The Egyptian Journal of Hospital Medicine “without informing other authors.”

When first author Ahmad Settin and the other authors sent it to the IJD in 2009, they were told its small sample size made it a letter to the editor; they decided to “decline submission” and send it to to Acta Dermatovenerologica Alpina, Pannonica et Adriatica, where it was published later that year. When Acta discovered the first version, it retracted the paper in 2013.

Meanwhile, editors at the IJD ended up posting the article, “Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt,” in 2011 without telling the authors. So they, too, now have to retract it:

Continue reading Skin study retracted twice in triple publication rub

Weekend reads: Journal invents time machine; endless author lists; is nuance overrated?

booksThe week at Retraction Watch featured the unmasking of the people behind PubPeer, and an editor doing the right thing following a high-profile retraction. Here’s what was happening elsewhere: Continue reading Weekend reads: Journal invents time machine; endless author lists; is nuance overrated?

Investigation leads to retraction of breast cancer paper, second for one author

Journal of Biological Chemistry.coverThe authors of a Journal of Biological Chemistry paper on a breast cancer gene are withdrawing it following an investigation at Roswell Park Cancer Institute that found a figure contained “manipulated” data.

Last author Toru Ouchi is based at Roswell in the department of cancer genetics.

Second to last author Sam W. Lee, at Massachusetts General Hospital, lost a Molecular Cell paper in 2013 after some figures were “inappropriately manipulated.”

Here’s the withdrawal note from JBC (which, unusually — but happily so — includes some explanation of what’s wrong with the paper): Continue reading Investigation leads to retraction of breast cancer paper, second for one author

“Whoops.” Paper cites retracted gay canvassing paper — but blame me, says journal editor

arch sex behavBy now, most Retraction Watch readers are likely familiar with the retraction in May of a much-ballyhooed study in Science on whether gay canvassers could persuade people to agree with same-sex marriage. It turns out that before that retraction appeared, a different study that cited the Science paper made its way online.

Kenneth Zucker, the editor of Archives of Sexual Behavior, which published the study online in February, 2015, decided he had some ‘splaining to do. The article has now been published as the lead paper in the current issue of the journal, which also includes a comment from Zucker. He explains what happened: Continue reading “Whoops.” Paper cites retracted gay canvassing paper — but blame me, says journal editor